Singapore markets closed

Vicarious Surgical Inc. (RBOT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
3.3500-0.1000 (-2.90%)
At close: 04:00PM EDT
3.3500 0.00 (0.00%)
After hours: 05:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.4500
Open3.4100
Bid3.2000 x 800
Ask3.4000 x 800
Day's range3.3300 - 3.5400
52-week range2.8200 - 14.1200
Volume105,716
Avg. volume189,464
Market cap407.752M
Beta (5Y monthly)N/A
PE ratio (TTM)23.93
EPS (TTM)N/A
Earnings date08 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est9.75
  • Business Wire

    Vicarious Surgical to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

    WALTHAM, Mass., August 17, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Management is scheduled to present on Wednesday, August 31, 2022 at 11:30 am ET.

  • Business Wire

    Vicarious Surgical Reports Second Quarter 2022 Financial Results

    WALTHAM, Mass., August 08, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended June 30, 2022. Management will host a corresponding conference call at 4:30 p.m. ET today, August 8, 2022.

  • Business Wire

    Vicarious Surgical to Present at the Canaccord Genuity 42nd Annual Growth Conference

    WALTHAM, Mass., July 27, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the company will participate in the Canaccord Genuity 42nd Annual Growth Conference.